Skip to main content
Clinical Trials/SLCTR/2014/018
SLCTR/2014/018
Recruiting
Phase 2

Pilot Study - Assessing the Impact of Using a Neuromuscular Blocking Agent to Reduce Neuromuscular Junction Damage and Intermediate Syndrome in Organophosphorus (OP) Insecticide Poisoned Patients Requiring Ventilation

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Organophosphate poisoning
Sponsor
South Asian Clinical Toxicology Research Collaboration
Enrollment
45
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Male or female
  • 2\. Age over 16 years
  • 3\. Clinical diagnosis of OP insecticide poisoning
  • 4\. Admission to Intensive Care Unit for ventilation
  • 5\. Informed consent from family
  • 6\. An initial Train\-of\-Four measurement (Neuromuscular junction function) of \> 50% using standard anaesthetic neurophysiology equipment

Exclusion Criteria

  • 1\.Failure to obtain informed consent from patient’s family
  • 2\.Age 16 years or younger
  • 3\.Patients who are pregnant
  • 4\.Patients will be removed from the study at their own or their family’s request

Outcomes

Primary Outcomes

Not specified

Similar Trials